Home › Funds › Ranger Investment Management, L.P. › ANIP
Ranger Investment Management, L.P. position in ANIP
ANI PHARMACEUTICALS INC · Health Care
Ranger Investment Management, L.P. reported holding 268,628 shares of ANIP (ANI PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$19.5M, representing 1.83% of its reported portfolio and ranking #13 among its reported holdings. Ranger Investment Management, L.P. has disclosed ANIP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Ranger Investment Management, L.P.'s ANIP position evolved
Ranger Investment Management, L.P. first disclosed a stake in ANIP in Q3 2023 at 426,848 shares (US$24.8M). The position peaked in Q1 2025 at 571,638 shares, worth US$38.3M. Across 13 filings, Ranger Investment Management, L.P. increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 268,628 shares valued at US$19.5M — a reduction of -74,522 shares quarter over quarter.. Notable position changes include a 46% increase in Q3 2024 (shares fell 7% over the following quarter), a 49% trim in Q3 2025 (shares fell 14% over the following quarter), a 34% increase in Q4 2025 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 426.85K | $24.78M | New |
| Q4 2023 | 434.62K | $23.96M | Add |
| Q1 2024 | 402.20K | $27.80M | Reduce |
| Q2 2024 | 402.73K | $25.65M | Hold |
| Q3 2024 | 589.69K | $35.18M | Add |
| Q4 2024 | 577.74K | $31.94M | Reduce |
| Q1 2025 | 571.64K | $38.27M | Reduce |
| Q2 2025 | 534.23K | $34.86M | Reduce |
| Q3 2025 | 271.35K | $24.86M | Reduce |
| Q4 2025 | 362.38K | $28.61M | Add |
| Q1 2026 | 360.08K | $27.69M | Reduce |
| Q2 2026 | 343.15K | $28.41M | Reduce |
| Q3 2026 | 268.63K | $19.52M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANIP and 13F data
ANIP (ANI PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in ANIP — the largest reported positions include Soleus Capital Management, L.P. (US$71.8M), TANG CAPITAL MANAGEMENT LLC (US$58.6M), Empyrean Capital Partners, LP (US$29.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANIP
- Soleus Capital Management, L.P. 867.76K sh · $71.83M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 707.50K sh · $58.57M · Q2 2026
- Empyrean Capital Partners, LP 23.00M sh · $29.75M · Q2 2026
- HBK INVESTMENTS L P 20.15M sh · $26.12M · Q2 2026
- Ikarian Capital, LLC 272.08K sh · $22.52M · Q2 2026
- Parkman Healthcare Partners LLC 202.91K sh · $16.80M · Q2 2026
- Boussard & Gavaudan Investment Management LLP 13.35K sh · $16.46M · Q1 2026
More on Ranger Investment Management, L.P.
FAQ
How long has Ranger Investment Management, L.P. held ANIP?
Ranger Investment Management, L.P. has disclosed ANIP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Ranger Investment Management, L.P.'s current position in ANIP?
As of Q3 2026, Ranger Investment Management, L.P. holds 268.63K shares of ANIP (ANI PHARMACEUTICALS INC), valued at $19.52M, representing 1.83% of its reported portfolio and ranking #13.
Has Ranger Investment Management, L.P. been buying or selling ANIP?
In the latest 13F filing (Q3 2026), Ranger Investment Management, L.P. reduced its position in ANIP. The position peaked in Q1 2025 at 571.64K shares.
Which other funds hold ANIP?
Other major institutional holders of ANIP include Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, Empyrean Capital Partners, LP, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.